-
A study by the Rand Corp., a nonpartisan research organization, found that, across all drugs, U.S. prices were 2.78 times higher than the prices in 33 OECD countries. The gap was even larger for brand-name drugs.
-
For years, addiction response teams have traveled around Florida to connect people who have overdosed on opioids with resources and recovery centers. Now, a handful have a new tool in their kit.
-
A judge had ruled the state had the authority to enter settlements with the pharmaceutical industry that trumped lawsuits pursued by the hospital districts and school boards.
-
Drugmakers offer copay assistance programs to patients, but insurers are tapping into those funds, not counting the amounts toward patient deductibles. That leads to unexpected charges. But the practice is under growing scrutiny.
-
A restructuring of the Medicare drug benefit has wiped out big drug bills for people who need expensive medicines. But the legal battle over drug negotiations means uncertainty over long-term savings.
-
It’s a big job clearing out so-called “patent thickets” drugmakers create to keep their products’ prices high. But the Federal Trade Commission is giving it a shot.
-
As national distributors and pharmacies restricted the flow of painkillers in response to the opioid crisis, Florida’s most popular grocer did the opposite, according to a Tampa Bay Times data analysis.
-
It's our monthly medical roundtable, when we dive into the month's most significant health headlines.
-
Florida Hospital Association president Mary Mayhew tells "The Florida Roundup" that she hopes people can start benefitting from the program within the year.
-
The FDA said Florida’s program will be authorized for two years. Approval comes after months of wrangling that led to the state filing two lawsuits against the agency.